Clinical Trials Logo

Clinical Trial Summary

Cystic lesions of the pancreas are frequent with a risk of degeneration into adenocarcinoma with pejorative prognosis. IPMNs require characterization to clarify their potential for degeneration. Clinical and morphological risk factors for degeneration determine the monitoring rate and the indication for pancreatic surgery. Pancreatic surgery remains invasive with high morbidity and mortality rates.


Clinical Trial Description

This is a monoservice and monocentric retrospective study at the Nancy CHRU. We will study the risk factors for IPMNs degeneration in order to determine the most sensitive and specific. To do this, we will use high-grade dysplasia or invasive cancer on the histological analysis of surgical specimens as the primary endpoint. The study population will be patients with Branch Duct, Main Duct or mixed IPMNs operated at the Nancy CHRU between September 2009 and October 2021. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04901364
Study type Observational
Source Central Hospital, Nancy, France
Contact Remy RF FONTANIE
Phone 0616297216
Email remyfontanie@yahoo.fr
Status Recruiting
Phase
Start date May 10, 2021
Completion date October 30, 2021